semaglutide 2.0 mg approval Canada approves generic from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Weight-loss drugs cost CT up

Access disparities exist, with studies suggesting lower utilization rates among Black, Hispanic, and other minority populations despite higher rates of diabetes and obesity in these communities

Recipient Safety: Even in small amounts, certain medications in donated blood could be harmful to a vulnerable recipient, such as a pregnant woman, a newborn baby, an immunocompromised patient, or someone with specific allergies

This is particularly relevant in the context of semaglutide, where variability in treatment response may be influenced by baseline microbial composition and host-specific factors [82]

Hsu TM, Hahn JD, Konanur VR, Lam A, Kanoski SE

J., and Orskov C

Its time we stop the judgment